We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$463B
AUM Growth
+$17.5B
Cap. Flow
-$1.61B
Cap. Flow %
-0.35%
Top 10 Hldgs %
12.49%
Holding
2,596
New
97
Increased
1,091
Reduced
793
Closed
67

Sector Composition

Rank Sector Weight
1 Healthcare 16.64%
2 Consumer Discretionary 13.46%
3 Financials 12.79%
4 Industrials 12.13%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MITT
2151
TPG Mortgage Investment Trust
MITT
$214M
$310K ﹤0.01%
5,467
HTH icon
2152
Hilltop Holdings
HTH
$2.28B
$308K ﹤0.01%
14,499
EPIQ
2153
DELISTED
EPIQ SYSTEMS INC
EPIQ
$308K ﹤0.01%
21,900
CONN
2154
DELISTED
Conn's Inc.
CONN
$306K ﹤0.01%
6,200
BLT
2155
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
$306K ﹤0.01%
21,677
BRC icon
2156
Brady Corp
BRC
$4.43B
$305K ﹤0.01%
10,200
-3,500
-26% -$94K
OPCH icon
2157
Option Care Health
OPCH
$3.61B
$304K ﹤0.01%
9,125
BSFT
2158
DELISTED
BroadSoft, Inc.
BSFT
$303K ﹤0.01%
11,500
CBR
2159
DELISTED
CIBER Inc.
CBR
$303K ﹤0.01%
61,340
ARIA
2160
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$303K ﹤0.01%
47,500
DNP icon
2161
DNP Select Income Fund
DNP
$4.11B
$301K ﹤0.01%
28,625
SPB icon
2162
Spectrum Brands
SPB
$2.09B
$301K ﹤0.01%
3,500
SBSI icon
2163
Southside Bancshares
SBSI
$984M
$300K ﹤0.01%
11,723
-1
-0% -$25
VPG icon
2164
Vishay Precision Group
VPG
$908M
$300K ﹤0.01%
18,241
MWW
2165
DELISTED
Monster Worldwide Inc
MWW
$300K ﹤0.01%
45,900
INFN
2166
DELISTED
Infinera Corporation Common Stock
INFN
$299K ﹤0.01%
32,500
+7,900
+32% +$70.2K
GOV
2167
DELISTED
Government Properties Income Trust
GOV
$297K ﹤0.01%
11,700
FSS icon
2168
Federal Signal
FSS
$7.51B
$296K ﹤0.01%
20,200
+8,500
+73% +$124K
ELX
2169
DELISTED
EMULEX CORP
ELX
$296K ﹤0.01%
51,900
CACC icon
2170
Credit Acceptance
CACC
$6.05B
$295K ﹤0.01%
2,400
ITG
2171
DELISTED
Investment Technology Group Inc
ITG
$295K ﹤0.01%
17,500
DRIV
2172
DELISTED
DIGITAL RIVER INC.
DRIV
$295K ﹤0.01%
19,100
AX icon
2173
Axos Financial
AX
$5.72B
$294K ﹤0.01%
16,000
+3,200
+25% +$63K
FHI icon
2174
Federated Hermes
FHI
$4.74B
$294K ﹤0.01%
9,500
ALCO icon
2175
Alico
ALCO
$304M
$292K ﹤0.01%
7,800

Similar funds

T. Rowe Price Associates's Q2 2014 Portfolio in Review

As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
  • T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
  • T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
  • T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
  • T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
  • T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.

Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.